American Injectables Inc.
American Injectables is a US-based sterile injectable manufacturer of parenteral drugs focused on ready-to-use pre-filled syringes and vials. The company’s product line includes small molecule 505(b)(2) NDA and 505(j) ANDA syringe and vial products. It also serves as a contract manufacturing partner for global pharmaceutical companies.
The company's strategy is also responsive to the US Government’s 2020 executive order supporting a revival of US-based manufacturing for essential medicines. American Injectables’ newly constructed facility includes state-of-the-art equipment and an integrated third-party analytical lab. It has a currently installed manufacturing capacity of 16 million units with an expansion capability of up to 50 million units.
Due to the recent global health crisis, American Injectables will focus initially on manufacturing generic parenteral products and other essential medicines to meet demand during this period of heightened drug shortages. COVID-19 has highlighted the importance of domestic supply chains and American Injectables seeks to be a leader in the effort to bring high-quality, cost-effective, sterile injectable manufacturing capabilities back to the US.
For more information click here.